Mativ Announces First Quarter 2025 Results
Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding.
Mativ First Quarter 2025 Highlights
-
Sales of
$484.8 million decreased 3.1% year over year, and 0.2% on an organic basis
-
GAAP loss was
$425.5 million , GAAP EPS was$(7.82) ; Results included a non-cash goodwill impairment charge of$411.9 million ($7.57 per share) as well as$14.5 million of organizational realignment and asset impairment expenses
-
Adjusted EBITDA was
$37.2 million , Adjusted loss was$6.0 million , and Adjusted EPS was$(0.14) , (see non-GAAP reconciliations). Adjusted EBITDA was down 19% versus the prior year, as lower SG&A expenses across both segments and higher volume/mix in our SAS segment were more than offset by higher manufacturing and distribution costs, unfavorable net selling price versus input cost performance, and lower volume/mix in our FAM segment.
Management Commentary
President and Chief Executive Officer
Our top priority is to accelerate our pace of execution with a focus on three key areas: driving enhanced commercial execution, sharpening our efforts to de-lever the balance sheet, and conducting a strategic review of our portfolio. These actions are to ensure
On a consolidated basis, our Q1 operating results, while mixed, came in as we expected at the start of the year. Our SAS segment delivered its fifth consecutive quarter of strong year-over-year results improvements, with organic revenue growth of approximately 6% and adjusted EBITDA growth of more than 3%, while FAM performance was impacted disproportionately by the higher priced year-end inventory we sold through during Q1, as well as continued slow demand in our transportation and construction-related end markets."
Mativ First Quarter 2025 Financial Results
Filtration & Advanced Materials (FAM) |
Three Months Ended |
|||||||||||||||
(in millions; unaudited) |
|
2025 |
|
|
|
2024 |
|
Change |
|
2025 |
|
|
2024 |
|
||
|
$ |
187.6 |
|
|
$ |
202.7 |
|
$ |
(15.1 |
) |
|
|
|
|
||
GAAP Operating Profit & Margin % |
$ |
(410.0 |
) |
|
$ |
14.6 |
|
$ |
(424.6 |
) |
|
(218.6 |
)% |
|
7.2 |
% |
Adjusted EBITDA & Margin % |
$ |
23.3 |
|
|
$ |
33.2 |
|
$ |
(9.9 |
) |
|
12.4 |
% |
|
16.4 |
% |
Filtration & Advanced Materials (FAM)
segment sales, comprised primarily of filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, were
GAAP Operating Profit in 2025 included
Sustainable & Adhesive Solutions (SAS) |
Three Months Ended |
||||||||||||||
(in millions; unaudited) |
|
2025 |
|
|
2024 |
|
Change |
|
2025 |
|
|
2024 |
|
||
|
$ |
297.2 |
|
$ |
297.5 |
|
$ |
(0.3 |
) |
|
|
|
|
||
GAAP Operating Profit & Margin % |
$ |
13.0 |
|
$ |
4.2 |
|
$ |
8.8 |
|
|
4.4 |
% |
|
1.4 |
% |
Adjusted EBITDA & Margin % |
$ |
33.3 |
|
$ |
32.3 |
|
$ |
1.0 |
|
|
11.2 |
% |
|
10.9 |
% |
Sustainable & Adhesive Solutions (SAS)
segment sales, comprised primarily of tapes, labels, liners, specialty paper, packaging and healthcare solutions, of
GAAP Operating Profit in 2025 included
Unallocated |
Three Months Ended |
||||||||||||||||
(in millions; unaudited) |
|
2025 |
|
|
|
2024 |
|
|
Change |
|
2025 |
|
|
2024 |
|
||
GAAP Operating Expense & % of Sales |
$ |
(33.6 |
) |
|
$ |
(32.6 |
) |
|
$ |
(1.0 |
) |
|
(6.9 |
)% |
|
(6.5 |
)% |
Adjusted EBITDA & % of Sales |
$ |
(19.4 |
) |
|
$ |
(19.7 |
) |
|
$ |
0.3 |
|
|
(4.0 |
)% |
|
(3.9 |
)% |
GAAP operating expenses
in 2025 included
Adjusted unallocated expenses (EBITDA)
(see non-GAAP reconciliations) decreased
Interest
expense
was
Other income (expense), net
was
Tax
was a 5.5% benefit for the three months ended
Non-GAAP Adjustments reflect items included in GAAP operating profit, income, and EPS, but excluded from adjusted results (see non-GAAP reconciliation tables for additional details). The most significant adjustment to the first quarter 2025 results were:
-
$6.35 per share of goodwill impairment expenses related to our FAM segment
-
$0.88 per share due to change of valuation allowance on tax attributes
-
$0.22 per share of purchase accounting expenses (purchase accounting expenses reflect primarily ongoing non-cash intangible asset amortizations associated with mergers and acquisitions)
Cash Flow & Debt
Year-to-date 2025 cash used in operating activities was
Total debt was
Dividend & Share Repurchases
On
During the first quarter, the Company did not repurchase shares.
Conference Call
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the incurrence of additional debt and expected maturities of the Company’s debt obligations, the adequacy of our sources of liquidity and capital, acquisition integration and growth prospects (including international growth), the cost and timing of our restructuring actions, the impact of ongoing litigation matters and environmental claims, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, impacts and timing of our ongoing operational excellence and other cost-reduction and cost-optimization initiatives, profitability, and cash flow, the expected benefits and accretion of the Neenah merger and Scapa acquisition and integration, whether the strategic benefits of the EP Divestiture can be achieved and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.
These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this release. These risks include, among other things, the following factors:
- Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
-
Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of
Mativ ;
- Adverse changes in our end-market sectors impacting key customers;
- Changes in the source and intensity of competition in our commercial end-markets;
- Adverse changes in sales or production volumes, pricing and/or manufacturing costs;
- Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
- Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
- Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
- Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
- Our ability to attract and retain key personnel, labor shortages, labor strikes, stoppages or other disruptions;
-
Changes in general economic, financial and credit conditions in the
U.S. ,Europe ,China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro) and on interest rates;
- A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
- Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
-
Changes in tax rates, the adoption of new
U.S. or international tax legislation or exposure to additional tax liabilities;
-
Uncertainty as to the long-term value of the common stock of
Mativ ;
-
Changes in employment, wage and hour laws and regulations in the
U.S. and elsewhere, including unionization rules and regulations by theNational Labor Relations Board , equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
- The impact of tariffs, and the imposition of any future additional tariffs and other trade barriers, and the effects of retaliatory trade measures;
- Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
- Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
-
International conflicts and disputes, such as the ongoing conflict between
Russia andUkraine , the war betweenIsrael andHamas and the broader regional conflict in theMiddle East , which restrict our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;
- Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
- Risks associated with pandemics and other public health emergencies;
- The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs;
- Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, as well as our ability to achieve our broader ESG goals and objectives;
- Costs and timing of implementation of any upgrades or changes to our information technology systems;
- Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
- Information technology system failures, data security breaches, network disruptions, and cybersecurity events; and
-
Other factors described elsewhere in this document and from time to time in documents that we file with the
SEC .
All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data. The financial results reported in this release are unaudited.
Non-GAAP Financial Measures
Certain financial measures and comments contained in this press release exclude restructuring and impairment expenses, certain purchase accounting adjustments related to prior acquisitions, organizational realignment and integration costs, divestiture costs, interest expense, stock compensation expense, inventory step-up expense, the effect of income tax provisions and other tax impacts, capital spending, capitalized software costs, cloud-based software costs and depreciation and amortization. This press release also provides certain information regarding the Company's financial results excluding currency impacts. This information estimates the impact of changes in foreign currency rates on the translation of the Company's current financial results as compared to the applicable comparable period and is derived by translating the current local currency results into
The Company believes that the presentation of non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency on the information used by the Company’s management in its financial and operational decision-making. Management also believes that the non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company’s financial and operational performance in the same way that management evaluates the Company's financial performance. Management believes that providing this information enables investors to better understand the Company’s operating performance and financial condition. These non-GAAP financial measures are not calculated or presented in accordance with, and are not intended to be considered in isolation or as alternatives or substitutes for, or superior to, financial measures prepared and presented in accordance with GAAP, and should be read only in conjunction with the Company's financial measures prepared and presented in accordance with GAAP. The non-GAAP financial measures used in this release may be different from the measures used by other companies.
CONSOLIDATED STATEMENTS OF INCOME (LOSS) (in millions, except per share amounts) (Unaudited) |
||||||||||
|
Three Months Ended |
|||||||||
|
|
2025 |
|
|
|
2024 |
|
|
% Change |
|
Net sales |
$ |
484.8 |
|
|
$ |
500.2 |
|
|
(3.1 |
)% |
Cost of products sold |
|
412.2 |
|
|
|
416.2 |
|
|
(1.0 |
)% |
Gross profit |
|
72.6 |
|
|
|
84.0 |
|
|
(13.6 |
)% |
|
|
|
|
|
|
|||||
Selling and general expense |
|
63.3 |
|
|
|
61.6 |
|
|
2.8 |
% |
Research and development expense |
|
6.3 |
|
|
|
6.0 |
|
|
5.0 |
% |
Intangible asset amortization expense |
|
15.4 |
|
|
|
15.8 |
|
|
(2.5 |
)% |
Total nonmanufacturing expenses |
|
85.0 |
|
|
|
83.4 |
|
|
1.9 |
% |
|
|
|
|
|
|
|||||
|
|
411.9 |
|
|
|
— |
|
|
N.M. |
|
Restructuring and other impairment expense |
|
6.3 |
|
|
|
14.4 |
|
|
(56.3 |
)% |
Operating loss |
|
(430.6 |
) |
|
|
(13.8 |
) |
|
N.M. |
|
Interest expense |
|
17.8 |
|
|
|
18.3 |
|
|
(2.7 |
)% |
Other income (expense), net |
|
(1.8 |
) |
|
|
1.7 |
|
|
N.M. |
|
Loss before income taxes |
|
(450.2 |
) |
|
|
(30.4 |
) |
|
N.M. |
|
Income tax benefit, net |
|
(24.7 |
) |
|
|
(2.4 |
) |
|
N.M. |
|
Net loss |
$ |
(425.5 |
) |
|
$ |
(28.0 |
) |
|
N.M. |
|
|
|
|
|
|
|
|||||
Net loss per share: |
|
|
|
|
|
|||||
Basic |
$ |
(7.82 |
) |
|
$ |
(0.52 |
) |
|
N.M. |
|
Diluted |
$ |
(7.82 |
) |
|
$ |
(0.52 |
) |
|
N.M. |
|
|
|
|
|
|
|
|||||
Weighted average shares outstanding: |
|
|
|
|
|
|||||
Basic |
|
54,447,200 |
|
|
|
54,267,900 |
|
|
|
|
Diluted |
|
54,447,200 |
|
|
|
54,267,900 |
|
|
|
N.M. - Not Meaningful |
CONSOLIDATED BALANCE SHEETS (in millions) (Unaudited) |
||||||
|
|
|
|
|||
ASSETS |
|
|
|
|||
Cash and cash equivalents |
$ |
84.0 |
|
|
$ |
94.3 |
Restricted cash |
|
9.8 |
|
|
|
— |
Accounts receivable, net |
|
202.1 |
|
|
|
162.4 |
Inventories, net |
|
346.0 |
|
|
|
355.1 |
Income taxes receivable |
|
19.0 |
|
|
|
20.6 |
Other current assets |
|
25.3 |
|
|
|
25.7 |
Total current assets |
|
686.2 |
|
|
|
658.1 |
Property, plant and equipment, net |
|
622.3 |
|
|
|
620.3 |
Finance lease right-of-use assets |
|
16.2 |
|
|
|
16.2 |
Operating lease right-of-use assets |
|
45.9 |
|
|
|
46.4 |
Deferred income tax assets |
|
9.6 |
|
|
|
8.1 |
|
|
54.8 |
|
|
|
465.6 |
Intangible assets, net |
|
545.4 |
|
|
|
553.4 |
Other assets |
|
71.9 |
|
|
|
79.8 |
Total assets |
$ |
2,052.3 |
|
|
$ |
2,447.9 |
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|||
Current debt |
$ |
2.7 |
|
|
$ |
2.6 |
Finance lease liabilities |
|
1.7 |
|
|
|
1.6 |
Operating lease liabilities |
|
9.2 |
|
|
|
9.5 |
Accounts payable |
|
176.9 |
|
|
|
151.7 |
Income taxes payable |
|
8.6 |
|
|
|
8.4 |
Accrued expenses and other current liabilities |
|
89.0 |
|
|
|
100.7 |
Total current liabilities |
|
288.1 |
|
|
|
274.5 |
Long-term debt |
|
1,120.1 |
|
|
|
1,086.7 |
Finance lease liabilities, noncurrent |
|
16.5 |
|
|
|
16.3 |
Operating lease liabilities, noncurrent |
|
36.2 |
|
|
|
36.4 |
Pension and other postretirement benefits |
|
54.9 |
|
|
|
54.3 |
Deferred income tax liabilities |
|
77.1 |
|
|
|
100.9 |
Other liabilities |
|
31.2 |
|
|
|
20.3 |
Total liabilities |
|
1,624.1 |
|
|
|
1,589.4 |
Stockholders' equity: |
|
|
|
|||
Preferred stock, |
|
— |
|
|
|
— |
Common stock, |
|
5.5 |
|
|
|
5.4 |
Additional paid-in-capital |
|
678.4 |
|
|
|
675.7 |
Retained earnings (accumulated deficit) |
|
(266.9 |
) |
|
|
164.3 |
Accumulated other comprehensive income, net of tax |
|
11.2 |
|
|
|
13.1 |
Total stockholders' equity |
|
428.2 |
|
|
|
858.5 |
Total liabilities and stockholders' equity |
$ |
2,052.3 |
|
|
$ |
2,447.9 |
CONSOLIDATED STATEMENTS OF CASH FLOW (in millions) (Unaudited) |
|||||||
|
Three Months Ended |
||||||
|
|
2025 |
|
|
|
2024 |
|
Operating |
|
|
|
||||
Net loss |
$ |
(425.5 |
) |
|
$ |
(28.0 |
) |
Adjustments to reconcile Net loss to Net cash used in operations: |
|
|
|
||||
Depreciation and amortization |
|
35.3 |
|
|
|
36.3 |
|
Amortization of deferred issuance costs |
|
2.0 |
|
|
|
2.0 |
|
|
|
411.9 |
|
|
|
— |
|
Other impairments |
|
5.3 |
|
|
|
— |
|
Deferred income tax |
|
(27.3 |
) |
|
|
(9.4 |
) |
Pension and other postretirement benefits |
|
(0.5 |
) |
|
|
(1.4 |
) |
Stock-based compensation |
|
3.6 |
|
|
|
2.7 |
|
(Gain) loss on foreign currency transactions |
|
1.8 |
|
|
|
(0.7 |
) |
Other non-cash items |
|
0.2 |
|
|
|
(1.2 |
) |
Other operating |
|
(0.6 |
) |
|
|
(0.6 |
) |
Net changes in operating working capital |
|
(22.1 |
) |
|
|
(12.7 |
) |
Net cash used in operations |
|
(15.9 |
) |
|
|
(13.0 |
) |
Investing |
|
|
|
||||
Capital spending |
|
(13.9 |
) |
|
|
(12.1 |
) |
Proceeds from sale of assets |
|
— |
|
|
|
2.0 |
|
Cash received from settlement of cross-currency swap contracts |
|
3.4 |
|
|
|
— |
|
Other investing |
|
(0.1 |
) |
|
|
1.0 |
|
Net cash used in investing of: |
|
|
|
||||
Continuing operations |
|
(10.6 |
) |
|
|
(9.1 |
) |
Discontinued operations |
|
— |
|
|
|
(12.0 |
) |
Net cash used in investing |
|
(10.6 |
) |
|
|
(21.1 |
) |
Financing |
|
|
|
||||
Cash dividends paid |
|
(5.5 |
) |
|
|
(5.4 |
) |
Proceeds from long-term debt |
|
54.0 |
|
|
|
69.0 |
|
Payments on long-term debt |
|
(22.7 |
) |
|
|
(16.7 |
) |
Payments on financing lease obligations |
|
(0.2 |
) |
|
|
(0.4 |
) |
Shares withheld for employee taxes |
|
(1.1 |
) |
|
|
(0.7 |
) |
Net cash provided by financing |
|
24.5 |
|
|
|
45.8 |
|
Effect of exchange rate changes on Cash and cash equivalents and Restricted cash |
|
1.5 |
|
|
|
(3.0 |
) |
Increase (decrease) in cash and cash equivalents and Restricted cash |
|
(0.5 |
) |
|
|
8.7 |
|
Cash and cash equivalents and Restricted cash at beginning of period |
|
94.3 |
|
|
|
120.2 |
|
Cash and cash equivalents and Restricted cash at end of period |
$ |
93.8 |
|
|
$ |
128.9 |
|
BUSINESS SEGMENT REPORTING (in millions) (Unaudited) |
|||||
Segment Results |
|
|
|
||
|
Three Months Ended |
||||
|
|
2025 |
|
|
2024 |
Net sales |
|
|
|
||
FAM |
$ |
187.6 |
|
$ |
202.7 |
SAS |
|
297.2 |
|
|
297.5 |
Total Consolidated |
$ |
484.8 |
|
$ |
500.2 |
|
|
|
|
||
Cost of products sold |
|
|
|
||
FAM |
$ |
155.5 |
|
$ |
160.2 |
SAS |
|
256.7 |
|
|
256.0 |
Consolidated |
$ |
412.2 |
|
$ |
416.2 |
|
|
|
|
||
Total nonmanufacturing expenses |
|
|
|
||
FAM |
$ |
24.2 |
|
$ |
24.7 |
SAS |
|
27.2 |
|
|
29.1 |
Total segments |
|
51.4 |
|
|
53.8 |
Unallocated |
|
33.6 |
|
|
29.6 |
Consolidated |
$ |
85.0 |
|
$ |
83.4 |
|
|
|
|
||
Restructuring and impairment |
|
|
|
||
FAM |
$ |
417.9 |
|
$ |
3.2 |
SAS |
|
0.3 |
|
|
8.2 |
Total segments |
|
418.2 |
|
|
11.4 |
Unallocated |
|
— |
|
|
3.0 |
Consolidated |
$ |
418.2 |
|
$ |
14.4 |
Operating profit (loss) |
|||||||||||||
|
Three Months Ended |
||||||||||||
|
|
|
|
|
Return on |
||||||||
|
|
2025 |
|
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
FAM |
$ |
(410.0 |
) |
|
$ |
14.6 |
|
|
(218.6 |
)% |
|
7.2 |
% |
SAS |
|
13.0 |
|
|
|
4.2 |
|
|
4.4 |
% |
|
1.4 |
% |
Unallocated |
|
(33.6 |
) |
|
|
(32.6 |
) |
|
(6.9 |
)% |
|
(6.5 |
)% |
Total Consolidated |
$ |
(430.6 |
) |
|
$ |
(13.8 |
) |
|
(88.8 |
)% |
|
(2.8 |
)% |
Non-GAAP Adjustments to Operating Profit (Loss) |
|
|
|
|||
|
Three Months Ended
|
|||||
|
|
2025 |
|
|
2024 |
|
FAM - Amortization of intangibles and other purchase accounting adjustments |
$ |
8.5 |
|
$ |
8.7 |
|
FAM - Restructuring, restructuring related, and impairment expenses |
|
417.9 |
|
|
3.2 |
|
SAS - Amortization of intangibles and other purchase accounting adjustments |
|
6.9 |
|
|
7.2 |
|
SAS - Restructuring, restructuring related, and impairment expenses |
|
0.3 |
|
|
7.6 |
|
SAS - Organizational realignment and integration costs(2) |
|
— |
|
|
(0.1 |
) |
Unallocated - Restructuring, restructuring related, and impairment expenses |
|
— |
|
|
3.1 |
|
Unallocated - Organizational realignment and integration costs(2) |
|
9.2 |
|
|
4.4 |
|
Unallocated - Divestiture costs |
|
0.8 |
|
|
1.5 |
|
Unallocated - Financing fees(1) |
|
2.0 |
|
|
2.4 |
|
Unallocated - Amortization of cloud-based software costs |
|
0.2 |
|
|
— |
|
Total Consolidated |
$ |
445.8 |
|
$ |
38.0 |
|
(1) Financing fees incurred for the Receivables Sales Agreement. |
(2) Costs associated with the organizational realignment plan (“the Plan”) announced on |
Adjusted Operating Profit |
|
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||||
|
|
|
|
|
Return on |
||||||||
|
|
2025 |
|
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
FAM |
$ |
16.4 |
|
|
$ |
26.5 |
|
|
8.7 |
% |
|
13.1 |
% |
SAS |
|
20.2 |
|
|
|
18.9 |
|
|
6.8 |
% |
|
6.4 |
% |
Unallocated |
|
(21.4 |
) |
|
|
(21.2 |
) |
|
(4.4 |
)% |
|
(4.2 |
)% |
Total Consolidated |
$ |
15.2 |
|
|
$ |
24.2 |
|
|
3.1 |
% |
|
4.8 |
% |
Non-GAAP Adjustments to Adjusted Operating Profit |
|
|
|
||
|
Three Months Ended
|
||||
|
|
2025 |
|
|
2024 |
FAM - Depreciation |
$ |
6.6 |
|
$ |
6.6 |
FAM - Stock-based compensation(1) |
|
0.3 |
|
|
0.1 |
SAS - Depreciation |
|
12.7 |
|
|
13.4 |
SAS - Stock-based compensation(1) |
|
0.4 |
|
|
— |
Unallocated - Depreciation |
|
0.6 |
|
|
0.5 |
Unallocated - Stock-based compensation(1) |
|
1.4 |
|
|
1.0 |
Total Consolidated |
$ |
22.0 |
|
$ |
21.6 |
(1) Stock-based compensation excludes stock-based compensation included in restructuring and organizational realignment and integration costs. |
Adjusted EBITDA |
|
|
|
|
|
|
|
||||||
|
Three Months Ended |
||||||||||||
|
|
|
|
|
Return on |
||||||||
|
|
2025 |
|
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
FAM |
$ |
23.3 |
|
|
$ |
33.2 |
|
|
12.4 |
% |
|
16.4 |
% |
SAS |
|
33.3 |
|
|
|
32.3 |
|
|
11.2 |
% |
|
10.9 |
% |
Unallocated |
|
(19.4 |
) |
|
|
(19.7 |
) |
|
(4.0 |
)% |
|
(3.9 |
)% |
Total Consolidated |
$ |
37.2 |
|
|
$ |
45.8 |
|
|
7.7 |
% |
|
9.2 |
% |
Non-GAAP Reconciliation of Organic Net Sales Growth |
|||||||||||
|
|
|
|
|
|
||||||
|
FAM |
|
SAS |
|
Consolidated |
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
$ |
202.7 |
|
|
$ |
297.5 |
|
|
$ |
500.2 |
|
Divestiture/closure adjustments |
|
— |
|
|
|
(16.3 |
) |
|
|
(16.3 |
) |
|
$ |
202.7 |
|
|
$ |
281.2 |
|
|
$ |
483.9 |
|
|
|
|
|
|
|
||||||
|
$ |
187.6 |
|
|
$ |
297.2 |
|
|
$ |
484.8 |
|
Divestiture/closure adjustments |
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
187.6 |
|
|
$ |
297.2 |
|
|
$ |
484.8 |
|
Organic growth |
|
(7.4 |
)% |
|
|
5.7 |
% |
|
|
0.2 |
% |
|
|
|
|
|
|
||||||
Currency effects on 2025 |
$ |
(2.1 |
) |
|
$ |
(2.6 |
) |
|
$ |
(4.7 |
) |
|
$ |
189.7 |
|
|
$ |
299.8 |
|
|
$ |
489.5 |
|
Organic constant currency growth |
|
(6.4 |
)% |
|
|
6.6 |
% |
|
|
1.2 |
% |
|
|
|
|
|
|
|
|||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA |
|||||||
(in millions, except per share amounts) |
|||||||
|
Three Months Ended
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Operating loss |
$ |
(430.6 |
) |
|
$ |
(13.8 |
) |
Plus: Restructuring, restructuring related, and impairment expenses |
|
6.3 |
|
|
|
13.9 |
|
Plus: |
|
411.9 |
|
|
|
— |
|
Plus: Purchase accounting adjustments |
|
15.4 |
|
|
|
15.9 |
|
Plus: Organizational realignment and integration costs |
|
9.2 |
|
|
|
4.3 |
|
Plus: Divestiture costs |
|
0.8 |
|
|
|
1.5 |
|
Plus: Financing fees |
|
2.0 |
|
|
|
2.4 |
|
Plus: Amortization of cloud-based software costs |
|
0.2 |
|
|
|
— |
|
Adjusted operating profit |
$ |
15.2 |
|
|
$ |
24.2 |
|
|
|
|
|
||||
Net loss |
$ |
(425.5 |
) |
|
$ |
(28.0 |
) |
Plus: Restructuring, restructuring related, and impairment expenses |
|
4.7 |
|
|
|
10.5 |
|
Plus: |
|
347.2 |
|
|
|
— |
|
Plus: Purchase accounting adjustments |
|
11.9 |
|
|
|
12.2 |
|
Plus: Organizational realignment and integration costs |
|
6.9 |
|
|
|
3.3 |
|
Plus: Divestiture costs |
|
0.6 |
|
|
|
1.1 |
|
Plus: Change of valuation allowance on tax attributes |
|
48.2 |
|
|
|
— |
|
Plus: Tax legislative changes, net of other discrete items |
|
— |
|
|
|
2.0 |
|
Adjusted income (loss) |
$ |
(6.0 |
) |
|
$ |
1.1 |
|
|
|
|
|
||||
Earnings (loss) per share - diluted |
$ |
(7.82 |
) |
|
$ |
(0.52 |
) |
Plus: Restructuring, restructuring related, and impairment expenses |
|
0.09 |
|
|
|
0.19 |
|
Plus: |
|
6.35 |
|
|
|
— |
|
Plus: Purchase accounting adjustments |
|
0.22 |
|
|
|
0.23 |
|
Plus: Organizational realignment and integration costs |
|
0.13 |
|
|
|
0.06 |
|
Plus: Divestiture costs |
|
0.01 |
|
|
|
0.02 |
|
Plus: Change of valuation allowance on tax attributes |
|
0.88 |
|
|
|
— |
|
Plus: Tax legislative changes, net of other discrete items |
|
— |
|
|
|
0.04 |
|
Adjusted Earnings (loss) per share - diluted |
$ |
(0.14 |
) |
|
$ |
0.02 |
|
|
|
|
|||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA |
|
|
|||||
(in millions, except per share amounts) |
|
|
|||||
|
Three Months Ended
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Net loss |
$ |
(425.5 |
) |
|
$ |
(28.0 |
) |
Plus: Interest expense |
|
17.8 |
|
|
|
18.3 |
|
Plus: Financing fees |
|
2.0 |
|
|
|
2.4 |
|
Plus: Provision for income taxes |
|
(24.7 |
) |
|
|
(2.4 |
) |
Plus: Depreciation & amortization |
|
35.3 |
|
|
|
36.4 |
|
Plus: Amortization of cloud-based software costs |
|
0.2 |
|
|
|
— |
|
Plus: Stock compensation expense |
|
2.1 |
|
|
|
1.1 |
|
Plus: Restructuring, restructuring related, and impairment expenses |
|
6.3 |
|
|
|
13.9 |
|
Plus: |
|
411.9 |
|
|
|
— |
|
Plus: Organizational realignment and integration costs |
|
9.2 |
|
|
|
4.3 |
|
Plus: Divestiture costs |
|
0.8 |
|
|
|
1.5 |
|
Plus: Other income (expense), net |
|
1.8 |
|
|
|
(1.7 |
) |
Adjusted EBITDA |
$ |
37.2 |
|
|
$ |
45.8 |
|
|
|
|
|
||||
Cash used in operating activities |
$ |
(15.9 |
) |
|
$ |
(13.0 |
) |
Less: Capital spending |
|
(13.9 |
) |
|
|
(12.1 |
) |
Less: Cloud-based software costs |
|
— |
|
|
|
(0.5 |
) |
Free cash flow |
$ |
(29.8 |
) |
|
$ |
(25.6 |
) |
|
|
|
|
||||
|
|
|
|
||||
Total debt |
$ |
1,122.8 |
|
|
$ |
1,089.3 |
|
Less: Cash |
|
84.0 |
|
|
|
94.3 |
|
Net debt |
$ |
1,038.8 |
|
|
$ |
995.0 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250507209497/en/
Director, Investor Relations
+1-770-569-4229
Website: http://www.mativ.com
Source: